Medications

Results from the VOYAGER PAD Trial reported

A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The ...

Oncology & Cancer

New tumor analysis method identifies high-risk prostate cancer

Scientists at Cedars-Sinai have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk. The new findings ...

Health

USPSTF recommends hep B screen for at-risk teens, adults

The U.S. Preventive Services Task Force (USPSTF) concludes that screening adults and adolescents at increased risk for hepatitis B virus (HBV) infection has moderate net benefit. These findings form the basis of a final recommendation ...

page 38 from 40